{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:04:18Z","timestamp":1783533858401,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009309","name":"Northern Ireland Chest Heart and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","award":["NC3Rs"],"award-info":[{"award-number":["NC3Rs"]}],"id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000362","name":"Asthma UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.chest.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T21:43:24Z","timestamp":1517348604000},"page":"1315-1325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["\u03b2-Blockers in COPD"],"prefix":"10.1016","volume":"153","author":[{"given":"Fran\u00e7ois","family":"Maltais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria C.","family":"Amatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gr\u00f6nke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Bothner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Vo\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorcan","family":"McGarvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary T.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.chest.2018.01.008_bib1","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000056767.69054.B3","article-title":"Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease","volume":"107","author":"Sin","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.chest.2018.01.008_bib2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1183\/13993003.01847-2015","article-title":"Beta-blockers in COPD: time for reappraisal","volume":"48","author":"Lipworth","year":"2016","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2018.01.008_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.08-2918","article-title":"A\u00a0postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation","volume":"136","author":"Zvezdin","year":"2009","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2018.01.008_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme\u2014a survey on the quality of care among patients with heart failure in Europe: Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.chest.2018.01.008_bib5","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","article-title":"Cardiovascular effects of \u03b2-agonists in patients with asthma and COPD: a meta-analysis","volume":"125","author":"Salpeter","year":"2004","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2018.01.008_bib6","first-page":"45","article-title":"Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice","volume":"4","author":"Ormiston","year":"2003","journal-title":"Heart Fail Monit"},{"issue":"2-3","key":"10.1016\/j.chest.2018.01.008_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/CRIAI:31:2:219","article-title":"Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids","volume":"31","author":"Salpeter","year":"2006","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.chest.2018.01.008_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.rmed.2016.11.011","article-title":"Long-term general and cardiovascular safety of tiotropium\/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease","volume":"122","author":"Buhl","year":"2017","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.chest.2018.01.008_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/thx.2010.136077","article-title":"Cardiovascular events in patients with COPD: TORCH study results","volume":"65","author":"Calverley","year":"2010","journal-title":"Thorax"},{"issue":"21","key":"10.1016\/j.chest.2018.01.008_bib10","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2011.02.020","article-title":"Heart failure and chronic obstructive pulmonary disease: the quandary of beta-blockers and beta-agonists","volume":"57","author":"Hawkins","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4A","key":"10.1016\/j.chest.2018.01.008_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0002-9343(83)90143-2","article-title":"Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with mild chronic obstructive pulmonary disease","volume":"75","author":"Light","year":"1983","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.chest.2018.01.008_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/eurjhf\/hfp066","article-title":"Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.chest.2018.01.008_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.amjcard.2012.03.019","article-title":"Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease","volume":"110","author":"Mainguy","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.chest.2018.01.008_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/COPD.S31236","article-title":"The association between COPD and heart failure risk: a review","volume":"8","author":"de Miguel Diez","year":"2013","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"10","key":"10.1016\/j.chest.2018.01.008_bib15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinternmed.2010.112","article-title":"Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease","volume":"170","author":"Rutten","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.chest.2018.01.008_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/thx.2007.081893","article-title":"Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD","volume":"63","author":"Dransfield","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2018.01.008_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2466-12-48","article-title":"Beta-blocker use and COPD mortality: a systematic review and meta-analysis","volume":"12","author":"Etminan","year":"2012","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.chest.2018.01.008_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/thoraxjnl-2015-207251","article-title":"Beta-blockers are associated with a reduction in COPD exacerbations","volume":"71","author":"Bhatt","year":"2016","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2018.01.008_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ahj.2007.10.040","article-title":"Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications","volume":"155","author":"Mascarenhas","year":"2008","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.chest.2018.01.008_bib20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1183\/09031936.00136014","article-title":"Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4)","volume":"45","author":"Buhl","year":"2015","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2018.01.008_bib21","article-title":"Cardioselective beta-blockers for chronic obstructive pulmonary disease","author":"Salpeter","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.chest.2018.01.008_bib22","first-page":"e5","article-title":"Validity of chronic obstructive pulmonary disease diagnoses in a large administrative database","volume":"19","author":"Lacasse","year":"2012","journal-title":"Can Respir J"},{"issue":"12","key":"10.1016\/j.chest.2018.01.008_bib23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/thoraxjnl-2013-203465","article-title":"European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions","volume":"68","author":"Roberts","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2018.01.008_bib24","doi-asserted-by":"crossref","first-page":"d2549","DOI":"10.1136\/bmj.d2549","article-title":"Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study","volume":"342","author":"Short","year":"2011","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.chest.2018.01.008_bib25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/thoraxjnl-2012-201945","article-title":"Association between beta-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension","volume":"67","author":"Stefan","year":"2012","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.chest.2018.01.008_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1164\/rccm.201208-1565OC","article-title":"Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease","volume":"187","author":"Ekstrom","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2018.01.008_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1183\/13993003.01222-2016","article-title":"Beta-blockers and COPD: the show must go on","volume":"48","author":"Lopez-Campos","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2018.01.008_bib28","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. GOLD 2017 global strategy for the diagnosis, management and prevention of COPD. http:\/\/goldcopd.org\/gold-2017-global-strategy-diagnosis-management-prevention-copd\/. Accessed January 29,\u00a02018."},{"issue":"7","key":"10.1016\/j.chest.2018.01.008_bib29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s40265-017-0731-3","article-title":"Management of chronic obstructive pulmonary disease in patients with cardiovascular diseases","volume":"77","author":"Cazzola","year":"2017","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.chest.2018.01.008_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pupt.2014.04.005","article-title":"Effects of chronic administration of beta-blockers on airway responsiveness in a murine model of heart failure","volume":"28","author":"Rinaldi","year":"2014","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.chest.2018.01.008_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/eurjhf\/hfs022","article-title":"Chronic obstructive pulmonary disease: a slowly progressive cardiovascular disease masked by its pulmonary effects?","volume":"14","author":"Rutten","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.chest.2018.01.008_bib32","doi-asserted-by":"crossref","first-page":"e113048","DOI":"10.1371\/journal.pone.0113048","article-title":"Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.chest.2018.01.008_bib33","doi-asserted-by":"crossref","first-page":"e012292","DOI":"10.1136\/bmjopen-2016-012292","article-title":"\u03b2-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (\u03b2LOCK COPD): a randomised controlled study protocol","volume":"6","author":"Bhatt","year":"2016","journal-title":"BMJ Open"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218300801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218300801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:57:26Z","timestamp":1762124246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369218300801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0012369218300801"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2018.01.008","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Blockers in COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}